In vitro study shows atorvastatin and nano-atorvastatin effectively reduce Aggregatibacter actinomycetemcomitans, suggesting new treatment options.
Background: The emergence of resistance, side effects, and the high cost of drugs indicates a need for other therapeutic alternatives with similar properties but fewer side effects. Purpose: . Materials and Method: was assessed using the agar well diffusion and microbroth dilution tests. Water and chlorhexidine were considered as the negative and positive control groups. Kruskal-Wallis and Mann-Whitney tests were used to compare the size of the diameter of the non-growth halo. Data analysis was obtained using SPSS V.22, and the significance level was considered less than 0.05. Results: = 0.05). The findings of the microbroth dilution test showed that atorvastatin and nano-atorvastatin had the minimum inhibitory concentration of 0.039 and 0.002 µg/ml, respectively. Conclusion: . Therefore, these substances can be used as an additional drug in treating periodontal diseases.
No takes yet. Share an insight, caveat, or question.
Ramezani et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: